Objective:

To evaluate the safety and effectiveness of adaptive stereotactic body radiation therapy (SBRT) for treating prostate cancer in adults, focusing on both short-term and long-term outcomes.

Key Findings:

• The trial assesses the safety profile of adaptive SBRT over time, including specific side effects and quality of life metrics.
• Participants undergo follow-up phone calls and clinic visits to monitor side effects and overall wellbeing.

Interpretation:

Adaptive SBRT may provide a novel treatment approach for men with intermediate- or high-risk prostate cancer, with ongoing assessment of safety and efficacy.

Limitations:

• Exclusion of patients with certain prior treatments and conditions may limit generalizability and affect the applicability of results to a broader population.
• Specific eligibility criteria may restrict participant diversity, potentially impacting the study's findings.

Conclusion:

The trial aims to establish adaptive SBRT as a viable treatment option for prostate cancer, pending further results to confirm its safety and efficacy.